Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-15T20:54:20.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T20:57:58.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating the record is temporarily inaccessible. This prevents viewing of the trial information on the page.
    Difference
    19%
    Check dated 2026-09-24T20:48:50.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.7.0, replacing the previous v3.6.6, indicating a backend or content-management update to the site. This update does not appear to alter the study content or visible user information.
    Difference
    0.0%
    Check dated 2026-09-17T21:53:40.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    Publication entry added under Publications summarizing a new article on the analytical and clinical performance of the CLDN18.2 assay in SPOTLIGHT and GLOW, including author names and journal details. This enriches the study file with related publication information.
    Difference
    0.0%
    Check dated 2026-09-10T22:38:49.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A new line '2017 ( U.S. NIH Grant/Contract )' was added to the study's ID Numbers, signaling NIH funding support for the trial.
    Difference
    0.0%
    Check dated 2026-08-27T18:59:22.000Z thumbnail image

Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.